| |
| |
|
| Insider
Information: |
Ashkenazi Anat |
| Relationship: |
EVP & CFO |
| City: |
Palo Alto |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
82,453 |
|
|
Indirect Shares
|
190 |
|
|
| Direct
Value |
$31,358,425 |
|
|
|
Indirect Value
|
$139,367 |
|
|
| Total
Shares |
82,643 |
|
|
| Total
Value |
$31,497,792 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Varian Medical Systems Inc |
VAR |
Director |
2021-04-15 |
0 |
|
0 |
Premium* |
|
|
Maravai Lifesciences Holdings, I... |
MRVI |
Director |
2023-07-17 |
40,123 |
2020-11-19 |
0 |
Premium* |
|
|
Eli Lilly & Co |
LLY |
EVP & CFO |
2024-02-12 |
42,330 |
2024-02-12 |
190 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
11 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| LLY |
Eli Lilly & Co |
EVP & CFO |
• – – |
2024-02-12 |
4 |
A |
$737.26 |
$3,103,865 |
D/D |
4,210 |
42,330 |
0 |
- |
|
| MRVI |
Maravai Lifesciences Hold... |
Director |
– • – |
2023-07-17 |
4 |
A |
$0.00 |
$0 |
D/D |
24,000 |
40,123 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
EVP & CFO |
• – – |
2023-02-10 |
4 |
A |
$345.12 |
$2,309,888 |
D/D |
6,693 |
38,120 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
SVP & CFO |
• – – |
2022-02-09 |
4 |
A |
$243.27 |
$1,399,289 |
D/D |
5,752 |
31,427 |
0 |
- |
|
| VAR |
Varian Medical Systems In... |
Director |
• • – |
2021-04-15 |
4 |
D |
$0.00 |
$0 |
D/D |
(2,574) |
0 |
0 |
- |
|
| VAR |
Varian Medical Systems In... |
Director |
• • – |
2021-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,225 |
2,574 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
SVP & CFOOfficer |
• – – |
2021-02-09 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
253 |
|
% |
|
| LLY |
Eli Lilly & Co |
SVP & CFOOfficer |
• – – |
2021-02-09 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
17,700 |
|
% |
|
| LLY |
Eli Lilly & Co |
SVP & CFO |
• – – |
2021-02-08 |
4 |
A |
$205.77 |
$1,641,016 |
D/D |
7,975 |
25,675 |
0 |
- |
|
| MRVI |
Maravai Lifesciences Hold... |
Director |
– • – |
2020-11-19 |
4 |
A |
$0.00 |
$0 |
D/D |
11,852 |
11,852 |
0 |
- |
|
| VAR |
Varian Medical Systems In... |
Director |
• • – |
2020-02-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,349 |
1,349 |
0 |
- |
|
11 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
